Back to Screener

Healthcare

RegeneRx Biopharmaceuticals, Inc.(RGRX)

Live Price

Offline

$0.0006

+0.00% today

Window Change

+200.00%

Window

Jul 23, 2025 โ†’ Jun 17, 2026

Market Cap
โ€”
Revenue Growth
0.0%
EPS Growth
-7094.2%
Dividend Yield
0.0%

Coverage: 227 bars ยท Jul 23, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

RegeneRx Biopharmaceuticals, Inc. (RGRX) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 200.0% across the available one-year price window (Jul 23, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -7094.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -7094.2%, free cash flow +5.0% with operating margin -1826.4% and ROIC 1654.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RGRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

RGRX

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

RGRX Max Drawdown

-99.88%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for RGRX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMar 31, 2023
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Mar 31, 23
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 22
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 22
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 22
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 22
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 21
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Dec 31
โ€”
Nov 15, 21
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Nov 15
โ€”
Aug 6, 21
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Aug 6
โ€”
Mar 31, 21
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 20
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Dec 31
โ€”
Nov 13, 20
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Nov 13
โ€”
Aug 14, 20
-0.00
Est โ€”
โ€”
19.2B
Est 17.0B
+12.9%
Aug 14
โ€”
May 15, 20
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
May 15
โ€”
Dec 31, 19
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Dec 31
โ€”
Nov 14, 19
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Nov 14
โ€”
Aug 14, 19
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Aug 14
โ€”
May 15, 19
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
May 15
โ€”
Mar 29, 19
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Mar 29
โ€”
Nov 14, 18
-0.00
Est โ€”
โ€”
19.2B
Est โ€”
โ€”
Nov 14
โ€”
Aug 9, 18
-0.00
Est โ€”
โ€”
12.5B
Est โ€”
โ€”
Aug 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener